Published in Arch Surg on October 01, 1970
Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg (1992) 4.50
Identification of the target self-antigens in reperfusion injury. J Exp Med (2006) 2.38
Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc Natl Acad Sci U S A (2008) 1.97
Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection. J Clin Invest (2005) 1.70
Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J (2008) 1.63
Apoptosis is a major mode of cell death caused by ischaemia and ischaemia/reperfusion injury to the rat intestinal epithelium. Gut (1998) 1.61
High molecular weight polyethylene glycol (PEG 15-20) maintains mucosal microbial barrier function during intestinal graft preservation. J Surg Res (2013) 1.51
Hypoxia-inducible factor-1α-dependent protection from intestinal ischemia/reperfusion injury involves ecto-5'-nucleotidase (CD73) and the A2B adenosine receptor. J Immunol (2011) 1.48
Mandatory resection of strangulation marks in small bowel obstruction? World J Surg (2014) 1.44
HIF-1 mediates pathogenic inflammatory responses to intestinal ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol (2010) 1.44
The effect of sildenafil on an animal model for ischemic colitis. Dig Dis Sci (2008) 1.43
Effects of traumatic brain injury on intestinal contractility. Neurogastroenterol Motil (2013) 1.43
Relative importance of heat-labile enterotoxin in the causation of severe diarrheal disease in the gnotobiotic piglet model by a strain of enterotoxigenic Escherichia coli that produces multiple enterotoxins. Infect Immun (2004) 1.42
Pretreatment with ALDH2 agonist Alda-1 reduces intestinal injury induced by ischemia and reperfusion in mice. Clin Sci (Lond) (2017) 1.38
Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann Surg (1993) 1.34
The recovery of function and microcirculation in small intestinal loops following ischaemia. Gut (1972) 1.16
Functional and morphological changes of the gut barrier during the restitution process after hemorrhagic shock. World J Gastroenterol (2005) 1.16
Mesenteric vasoconstriction after endotoxin administration in cats pretreated with aspirin. Br J Pharmacol (1971) 1.15
Hypoxia-inducible factor plays a gut-injurious role in intestinal ischemia reperfusion injury. Am J Physiol Gastrointest Liver Physiol (2010) 1.11
Heparin-binding epidermal growth factor-like growth factor gene disruption is associated with delayed intestinal restitution, impaired angiogenesis, and poor survival after intestinal ischemia in mice. J Pediatr Surg (2008) 1.11
The mucus layer is critical in protecting against ischemia-reperfusion-mediated gut injury and in the restitution of gut barrier function. Shock (2011) 1.10
Response of the intestinal mucosa to ischaemia. Gut (1981) 1.09
Rapid reversal of human intestinal ischemia-reperfusion induced damage by shedding of injured enterocytes and reepithelialisation. PLoS One (2008) 1.08
TLR4-mediated Cox-2 expression increases intestinal ischemia/reperfusion-induced damage. J Leukoc Biol (2009) 1.06
Comparative protection against rat intestinal reperfusion injury by a new inhibitor of sPLA2, COX-1 and COX-2 selective inhibitors, and an LTC4 receptor antagonist. Br J Pharmacol (2003) 1.05
Gut ischaemia. Gut (1994) 1.04
Bone-marrow mesenchymal stem cells reduce rat intestinal ischemia-reperfusion injury, ZO-1 downregulation and tight junction disruption via a TNF-α-regulated mechanism. World J Gastroenterol (2013) 1.03
Cyclooxygenase-2 deficiency leads to intestinal barrier dysfunction and increased mortality during polymicrobial sepsis. J Immunol (2011) 1.03
The role of the intestine in the pathophysiology and management of severe acute pancreatitis. HPB (Oxford) (2003) 1.01
Elemental diet-induced bacterial translocation can be hormonally modulated. Ann Surg (1993) 0.99
Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion. Mol Immunol (2010) 0.99
Human natural IgM can induce ischemia/reperfusion injury in a murine intestinal model. Mol Immunol (2008) 0.98
Mucosal lesions in the human small intestine in shock. Gut (1975) 0.96
Prophylactic use of epidermal growth factor reduces ischemia/reperfusion intestinal damage. Am J Pathol (2002) 0.96
Depletion of intestinal resident macrophages prevents ischaemia reperfusion injury in gut. Gut (2004) 0.96
Complement component C5a mediates hemorrhage-induced intestinal damage. J Surg Res (2008) 0.95
Role of bone marrow-derived mesenchymal stem cells in a rat model of severe acute pancreatitis. World J Gastroenterol (2012) 0.94
Erythropoietin protects the intestine against ischemia/ reperfusion injury in rats. Mol Med (2007) 0.94
Spleen tyrosine kinase inhibition prevents tissue damage after ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol (2010) 0.93
Ginsenoside Rb1 attenuates intestinal ischemia-reperfusion- induced liver injury by inhibiting NF-kappaB activation. Exp Mol Med (2008) 0.93
Protective effect of leptin against ischemia-reperfusion injury in the rat small intestine. BMC Gastroenterol (2005) 0.92
Role of myosin light chain kinase in intestinal epithelial barrier defects in a rat model of bowel obstruction. BMC Gastroenterol (2010) 0.92
Small intestinal permeability. 1. Effects of ischaemia and exposure to acetyl salicylate. Gut (1976) 0.92
Protective effects of curcumin against gamma radiation-induced ileal mucosal damage. Arch Toxicol (2008) 0.91
Intestinal mucus layer preservation in female rats attenuates gut injury after trauma-hemorrhagic shock. J Trauma (2010) 0.91
Removal of luminal content protects the small intestine during hemorrhagic shock but is not sufficient to prevent lung injury. Physiol Rep (2013) 0.91
Beneficial effects of intra-arterial and intravenous prostaglandin E1 in intestinal ischaemia-reperfusion injury. Interact Cardiovasc Thorac Surg (2014) 0.90
Changes of gastric and intestinal blood flow, serum phospholipase A2 and interleukin-1beta in rats with acute necrotizing pancreatitis. World J Gastroenterol (2005) 0.90
Ketamine anesthesia reduces intestinal ischemia/reperfusion injury in rats. World J Gastroenterol (2008) 0.90
Predicting the survival of experimental ischaemic small bowel using intraoperative near-infrared fluorescence angiography. Br J Surg (2011) 0.89
Synergistic effects of HB-EGF and mesenchymal stem cells in a murine model of intestinal ischemia/reperfusion injury. J Pediatr Surg (2013) 0.89
Increased phospholipase A2 and decreased lysophospholipase activity in the small intestinal mucosa after ischaemia and revascularisation. Gut (1987) 0.89
Protective effect of ginsenoside Rb1 against intestinal ischemia-reperfusion induced acute renal injury in mice. PLoS One (2013) 0.89
Lipopolysaccharide-induced failure of the gut barrier is site-specific and inhibitable by growth hormone. Inflamm Res (2013) 0.89
Probiotics prevent intestinal barrier dysfunction in acute pancreatitis in rats via induction of ileal mucosal glutathione biosynthesis. PLoS One (2009) 0.89
Gut hyperpermiability after ischemia and reperfusion: attenuation with adrenomedullin and its binding protein treatment. Int J Clin Exp Pathol (2008) 0.88
The role of curcumin on intestinal oxidative stress, cell proliferation and apoptosis after ischemia/reperfusion injury in rats. J Mol Histol (2011) 0.88
Intestinal NF-E2-related factor-2 expression and antioxidant activity changes in rats undergoing orthotopic liver autotransplantation. Oncol Lett (2013) 0.88
Involvement of neutrophils in postischaemic damage to the small intestine. Gut (1991) 0.87
The role of platelet factor 4 in local and remote tissue damage in a mouse model of mesenteric ischemia/reperfusion injury. PLoS One (2012) 0.87
Mice overexpressing the gene for heparin-binding epidermal growth factor-like growth factor (HB-EGF) have increased resistance to hemorrhagic shock and resuscitation. Surgery (2010) 0.87
Effect of nuclear factor kappa B on intercellular adhesion molecule-1 expression and neutrophil infiltration in lung injury induced by intestinal ischemia/reperfusion in rats. World J Gastroenterol (2006) 0.87
Proanthocyanidin protects intestine and remote organs against mesenteric ischemia/reperfusion injury. World J Surg (2009) 0.87
Different patterns of intestinal response to injury after arterial, venous or arteriovenous occlusion in rats. World J Gastroenterol (2009) 0.87
Modulating the p66shc signaling pathway with protocatechuic acid protects the intestine from ischemia-reperfusion injury and alleviates secondary liver damage. ScientificWorldJournal (2014) 0.86
Temporal relationship of serum markers and tissue damage during acute intestinal ischemia/reperfusion. Clinics (Sao Paulo) (2013) 0.86
Recombinant factor XIII diminishes multiple organ dysfunction in rats caused by gut ischemia-reperfusion injury. Shock (2009) 0.86
Domain V peptides inhibit beta2-glycoprotein I-mediated mesenteric ischemia/reperfusion-induced tissue damage and inflammation. J Immunol (2010) 0.86
Pyrrolidine dithiocarbamate reduces ischemia-reperfusion injury of the small intestine. World J Gastroenterol (2005) 0.86
Protective roles of hydroxyethyl starch 130/0.4 in intestinal inflammatory response and oxidative stress after hemorrhagic shock and resuscitation in rats. Inflammation (2009) 0.86
Isoflurane post-conditioning protects against intestinal ischemia-reperfusion injury and multiorgan dysfunction via transforming growth factor-β1 generation. Ann Surg (2012) 0.86
Animal models of ischemia-reperfusion-induced intestinal injury: progress and promise for translational research. Am J Physiol Gastrointest Liver Physiol (2014) 0.85
Radio-protective effect of catalpol in cultured cells and mice. J Radiat Res (2012) 0.85
Gut failure in critical care: old school versus new school. Ann Gastroenterol (2015) 0.85
Volume deficit versus toxic absorption: a study of canine shock after mesenteric arterial occlusion. Ann Surg (1972) 0.85
Metabolomic markers for intestinal ischemia in a mouse model. J Surg Res (2012) 0.84
Kampo medicine "Dai-kenchu-to" prevents CPT-11-induced small-intestinal injury in rats. Surg Today (2011) 0.84
Relationship between expression of triggering receptor-1 on myeloid cells in intestinal tissue and intestinal barrier dysfunction in severe acute pancreatitis. World J Emerg Med (2011) 0.84
Protective effect of exogenous IGF-I on the intestinalmucosal barrier in rats with severe acute pancreatitis. World J Emerg Med (2012) 0.84
Ketamine reduces intestinal injury and inflammatory cell infiltration after ischemia/reperfusion in rats. Surg Today (2010) 0.84
Ischemic Preconditioning-Induced SOCS-1 Protects Rat Intestinal Ischemia Reperfusion Injury via Degradation of TRAF6. Dig Dis Sci (2016) 0.84
Si-jun-zi decoction treatment promotes the restoration of intestinal function after obstruction by regulating intestinal homeostasis. Evid Based Complement Alternat Med (2014) 0.84
Tumor necrosis factor-α mediates JNK activation response to intestinal ischemia-reperfusion injury. World J Gastroenterol (2013) 0.83
Very short cycles of postconditioning have no protective effect against reperfusion injury. Experimental study in rats. Rev Bras Cir Cardiovasc (2015) 0.83
Hyperthermia induces injury to the intestinal mucosa in the mouse: evidence for an oxidative stress mechanism. Am J Physiol Regul Integr Comp Physiol (2012) 0.83
Preventive effect of tetramethylpyrazine on intestinal mucosal injury in rats with acute necrotizing pancreatitis. World J Gastroenterol (2006) 0.83
Combined early fluid resuscitation and hydrogen inhalation attenuates lung and intestine injury. World J Gastroenterol (2013) 0.83
Pretreatment of cromolyn sodium prior to reperfusion attenuates early reperfusion injury after the small intestine ischemia in rats. World J Gastroenterol (2007) 0.83
Influence of Ketotifen, Cromolyn Sodium, and Compound 48/80 on the survival rates after intestinal ischemia reperfusion injury in rats. BMC Gastroenterol (2008) 0.83
Intestinal lipid alterations occur prior to antibody-induced prostaglandin E2 production in a mouse model of ischemia/reperfusion. Biochim Biophys Acta (2010) 0.83
Remifentanil ameliorates intestinal ischemia-reperfusion injury. BMC Gastroenterol (2013) 0.83
Inhibition of ERK1/2 worsens intestinal ischemia/reperfusion injury. PLoS One (2013) 0.83
Protective role of p70S6K in intestinal ischemia/reperfusion injury in mice. PLoS One (2012) 0.83
Protective effects of caffeic acid phenethyl ester on intestinal ischemia-reperfusion injury. Dig Dis Sci (2008) 0.83
Effect of FR167653 on small bowel ischemia-reperfusion injury in dogs. Dig Dis Sci (1999) 0.82
Epidermal growth factor promotes proliferation and improves restoration after intestinal ischemia-reperfusion injury in rats. Inflammation (2013) 0.82
Surveillance of intra-abdominal pressure and intestinal barrier function in a rat model of acute necrotizing pancreatitis and its potential early therapeutic window. PLoS One (2013) 0.82
Polydatin Alleviates Small Intestine Injury during Hemorrhagic Shock as a SIRT1 Activator. Oxid Med Cell Longev (2015) 0.82
Dynamic changes of IL-2/IL-10, sFas and expression of Fas in intestinal mucosa in rats with acute necrotizing pancreatitis. World J Gastroenterol (2008) 0.82
Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg (1992) 4.26
Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study. Lancet (2000) 4.22
Insulin-regulatable tissues express a unique insulin-sensitive glucose transport protein. Nature (1988) 3.57
Nationalism and patriotism: national identification and out-group rejection. Br J Soc Psychol (2001) 3.33
Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature (1995) 3.22
Inactivation of the N-CAM gene in mice results in size reduction of the olfactory bulb and deficits in spatial learning. Nature (1994) 3.19
Prevalence of urethral Chlamydia trachomatis and Neisseria gonorrhoeae among asymptomatic, sexually active adolescent boys. J Infect Dis (1987) 3.02
Trauma care regionalization: a process-outcome evaluation. J Trauma (1999) 3.02
11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci U S A (1997) 3.00
A prospective assessment of mortality in chronic spinal cord injury. Spinal Cord (2005) 2.96
Clinical aspects of X-linked hypohidrotic ectodermal dysplasia. Arch Dis Child (1987) 2.95
Reaction of endotoxin and surfactants. I. Physical and biological properties of endotoxin treated with sodium deoxycholate. J Bacteriol (1966) 2.86
Evaluation of readability and accuracy of information leaflets in general practice for patients with asthma. BMJ (1998) 2.75
Cancer morbidity in rheumatoid arthritis. Ann Rheum Dis (1984) 2.67
Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet (1994) 2.53
Evidence for a polar ethane cloud on Titan. Science (2006) 2.50
The evolution of Titan's mid-latitude clouds. Science (2005) 2.46
Hand-held thoracic sonography for detecting post-traumatic pneumothoraces: the Extended Focused Assessment with Sonography for Trauma (EFAST). J Trauma (2004) 2.44
Human N-ras: cDNA cloning and gene structure. Nucleic Acids Res (1985) 2.41
The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature (1987) 2.38
An evaluation of the Gaspak system in the culture of anaerobic bacteria. J Appl Bacteriol (1972) 2.33
Symptoms of depression and survival experience among three samples of smokers trying to quit. Psychol Addict Behav (2001) 2.20
Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter. Cancer Res (2000) 2.17
Intramuscular rocuronium in infants and children. Dose-ranging and tracheal intubating conditions. Anesthesiology (1996) 2.14
Cause of death in rheumatoid arthritis. Br J Rheumatol (1984) 2.12
Loss of bacterial diversity during antibiotic treatment of intubated patients colonized with Pseudomonas aeruginosa. J Clin Microbiol (2007) 2.12
Insuring Latinos against the costs of illness. JAMA (1993) 2.09
Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trial. JAMA (2001) 2.06
A pharmacodynamic explanation for the rapid onset/offset of rapacuronium bromide. Anesthesiology (1999) 2.03
Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line. J Biol Chem (1996) 2.01
Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J Natl Cancer Inst (1985) 2.00
New cosmid vectors developed for eukaryotic DNA cloning. Gene (1984) 1.97
Acute infectious epiglottitis in adults. Ann Intern Med (1969) 1.97
Characterization of a broadly expressed human leucocyte surface antigen MEM-43 anchored in membrane through phosphatidylinositol. Mol Immunol (1989) 1.94
Training in international animal health. Vet Rec (2001) 1.93
EXPERIENCES WITH SODIUM AMYTAL AS A GENERAL ANAESTHETIC. Ann Surg (1930) 1.93
A death-domain-containing receptor that mediates apoptosis. Nature (1996) 1.92
An evaluated programme of rheumatology training for general practitioners. Br J Rheumatol (1986) 1.88
Hemoglobin desaturation after succinylcholine-induced apnea: a study of the recovery of spontaneous ventilation in healthy volunteers. Anesthesiology (2001) 1.84
Studies on the mode of action of diphtheria toxin. VII. Toxin-stimulated hydrolysis of nicotinamide adenine dinucleotide in mammalian cell extracts. J Exp Med (1969) 1.83
Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease. Hum Mol Genet (2001) 1.81
The recovery of anaerobic bacteria from swabs. J Hyg (Lond) (1974) 1.80
A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer. Oncogene (1999) 1.80
Epigenetics as a mechanism driving polygenic clinical drug resistance. Br J Cancer (2006) 1.77
Social work in general practice. J R Coll Gen Pract (1978) 1.74
Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry (1986) 1.74
Experience with elemental diet in the treatment of inflammatory bowel disease. Is this primary therapy? Arch Surg (1973) 1.72
Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer (1986) 1.70
A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet (2001) 1.69
Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes. Diabet Med (2011) 1.68
A scheme for the identification of clinical isolates of Gram-negative anaerobic bacilli by conventional bacteriological tests. J Med Microbiol (1980) 1.67
Homologous alpha satellite sequences on human acrocentric chromosomes with selectivity for chromosomes 13, 14 and 21: implications for recombination between nonhomologues and Robertsonian translocations. Nucleic Acids Res (1988) 1.67
Diagnostic lessons learnt from a series of enterovesical fistulae. Colorectal Dis (2002) 1.65
A study on the routes of referral for patients with colorectal cancer and its affect on the time to surgery and pathological stage. Colorectal Dis (2004) 1.63
Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells. Cancer Res (1996) 1.63
Human lung volumes and the mechanisms that set them. Eur Respir J (1999) 1.62
Activated N-ras controls the transformed phenotype of HT1080 human fibrosarcoma cells. Cell (1987) 1.58
A study of the acute and chronic respiratory pathophysiology of hemorrhagic shock. J Thorac Cardiovasc Surg (1967) 1.58
The effects of large negative intrathoracic pressure on left ventricular function in patients with coronary artery disease. Circulation (1981) 1.58
Resolution of invasive central nervous system aspergillosis in a transplant recipient. Bone Marrow Transplant (1997) 1.57
The isolation of strict anaerobes: the use of an anaerobic cabinet compared with a conventional procedure. J Med Microbiol (1974) 1.56
Colonic haemorrhage: a technique for rapid intra-operative bowel preparation and colonoscopy. Br J Surg (1986) 1.56
Mechanism of activation of an N-ras gene in the human fibrosarcoma cell line HT1080. EMBO J (1984) 1.56
Recovery of anaerobic bacteria from small inocula: a model for blood culture studies. J Clin Pathol (1977) 1.55
Successful use of a Sengstaken-Blakemore tube to control massive postpartum haemorrhage. Br J Obstet Gynaecol (1994) 1.54
How the elderly fare in HMOs: outcomes from the Medicare competition demonstrations. Health Serv Res (1992) 1.53
Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. Am J Pathol (2001) 1.53
New members of the Bcl-2 family and their protein partners. Curr Opin Genet Dev (1996) 1.52
Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol Cell Biol (1994) 1.51
Health and health needs of homeless and runaway youth. A position paper of the Society for Adolescent Medicine. J Adolesc Health (1992) 1.51
Direct transport to tertiary trauma centers versus transfer from lower level facilities: impact on mortality and morbidity among patients with major trauma. J Trauma (1997) 1.51
Molecular cloning of the human Goodpasture antigen demonstrates it to be the alpha 3 chain of type IV collagen. J Clin Invest (1992) 1.50
Holes in the Jackson Hole approach to health care reform. JAMA (1993) 1.49
Tissue pressure, posture, and venous ulceration. Lancet (1991) 1.48
Mucosa-associated bacterial flora of the human colon. J Med Microbiol (1997) 1.47
Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling. Oncogene (2012) 1.45
Improving the design of muscle relaxant studies. Stabilization period and tetanic recruitment. Anesthesiology (1997) 1.45
Alteration of exocrine pancreatic storage enzymes by feeding on an elemental diet: a biochemical and ultrastructural study. Surg Forum (1970) 1.44
Multiple system atrophy (Shy-Drager syndrome): MR imaging. Radiology (1986) 1.43
Preventable death evaluation of the appropriateness of the on-site trauma care provided by Urgences-Santé physicians. J Trauma (1995) 1.43
Too many serpents spoil the symbol. CMAJ (2001) 1.43
Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology (2002) 1.42
Prion-protein immunoreactivity in human transmissible dementias. N Engl J Med (1986) 1.42
Pulmonary thromboembolism during liver transplantation: possible association with antifibrinolytic drugs and novel treatment options. Anesth Analg (2000) 1.42
Field reversed configuration confinement enhancement through edge biasing and neutral beam injection. Phys Rev Lett (2012) 1.41
Clostridium difficile in association with sporadic diarrhoea. Br Med J (Clin Res Ed) (1982) 1.40
Quantitative analysis of collagen gel contractile forces generated by dermal fibroblasts and the relationship to cell morphology. J Cell Physiol (1996) 1.39
Lidocaine-induced spinal block can relieve central poststroke pain: role of the block in chronic pain diagnosis. Anesthesiology (1991) 1.39
Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity? Bone Marrow Transplant (2000) 1.39
Plateletapheresis with a next generation blood cell separator. J Clin Apher (1997) 1.39
Dynamic formation of a hot field reversed configuration with improved confinement by supersonic merging of two colliding high-β compact toroids. Phys Rev Lett (2010) 1.38
Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry (1989) 1.38
Treatment for Alzheimer's disease in people with learning disabilities: NICE guidance. Br J Psychiatry (2001) 1.38
Perforated diverticulitis following extra-abdominal surgery. Postgrad Med J (1997) 1.37
Access to care in Medicare HMOs, 1996. Health Aff (Millwood) (1997) 1.37
Rural interprofessional education: promoting teamwork in primary health care education and practice. Aust J Rural Health (2001) 1.35
Partial trisomy 12q associated with a familial translocation. Clin Genet (1979) 1.34